120 related articles for article (PubMed ID: 7650656)
1. Measuring quantitative serum human chorionic gonadotropin. Variations in levels between kits.
Smikle CB; Sorem KA; Wians FH; Hankins GD
J Reprod Med; 1995 Jun; 40(6):439-42. PubMed ID: 7650656
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
[TBL] [Abstract][Full Text] [Related]
3. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
5. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
8. [Value of immunoassay of hCG for the determination of high plasma concentrations].
Revol A; Badonnel Y; Bugugnani MJ; Delvigne L; Fiet J; Lacroix I; Patricot MC
Ann Biol Clin (Paris); 1995; 53(3):115-24. PubMed ID: 7574095
[TBL] [Abstract][Full Text] [Related]
9. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
10. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
11. Semiquantitative use of Biocept-G radioreceptorassay.
Hussa RO; Mattingly RF
Obstet Gynecol; 1979 Aug; 54(2):199-204. PubMed ID: 460754
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of slightly elevated serum human chorionic gonadotropin levels.
Bar-Hava I; Orvieto R; Homburg R; Dicker D; Ben-Rafael Z
Int J Fertil Menopausal Stud; 1994; 39(6):320-3. PubMed ID: 7889084
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Abbott IMx assay system for the measurement of human chorionic gonadotropin levels in the treatment of ectopic pregnancy.
Goodman DB; Bulley M; Hendricks M; Senior M
Arch Pathol Lab Med; 1993 Jul; 117(7):701-3. PubMed ID: 8323432
[TBL] [Abstract][Full Text] [Related]
15. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
Palomaki GE; Neveux LM; Haddow JE; Wyatt P
Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
[TBL] [Abstract][Full Text] [Related]
17. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
19. Phantom hCG and phantom choriocarcinoma.
Cole LA
Gynecol Oncol; 1998 Nov; 71(2):325-9. PubMed ID: 9826481
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of 10 kits for determination of human choriogonadotropin in serum.
Rasor JL; Farber S; Braunstein GD
Clin Chem; 1983 Oct; 29(10):1828-31. PubMed ID: 6616833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
